Compare StocksBSX vs CRM

Boston Scientific Corporation (BSX) vs Salesforce, Inc. (CRM): Which Is the Better Buy in 2026?

As of 2026-09-17, BSX is overvalued at $43, with a DCF intrinsic value of $30 and a margin of safety of -44%. CRM is overvalued at $245, with an intrinsic value of $158 and a margin of safety of -55%. Of the two, BSX has the wider margin of safety.

BSX
Boston Scientific Corporation
$43.09
VS
CRM
Salesforce, Inc.
$244.75

Rewards

BSX
  • Gross margin of 69.2% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 55.0% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $3.37 of earning power — management is an exceptional capital allocator.
CRM
  • Gross margin of 77.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 31.6% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $5.53 of earning power — management is an exceptional capital allocator.

Risks

BSX
  • FCF yield of 5.5% suggests reasonable valuation assuming continued moderate growth.
CRM

    Key Valuation Metrics

    Learn more →
    BSX
    CRM
    Valuation
    $3.40B
    Free Cash Flow
    $17.73B
    5.45%
    FCF Yield
    8.80%
    17.45
    Trailing P/E
    22.41
    12.58
    Forward P/E
    15.28
    Quality & Moat
    10.05%
    ROIC
    9.19%
    15.34%
    ROE
    19.38%
    69.19%
    Gross Margin
    77.28%
    0.62
    PEG Ratio
    0.87
    Balance Sheet Safety
    0.48
    Net Debt / Equity
    0.81
    N/A
    Interest Coverage
    N/A
    2.12
    Net Debt / EBITDA
    2.40
    0.00%
    Dividend Yield
    0.70%
    BSX: 6Ties: 1CRM: 5
    BSXCRM

    Historical Fundamentals

    Learn more →
    BSX

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    CRM

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    BSX
    $11.89
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $6.32B
    Δ Market Cap
    +$75.08B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    CRM
    $-2.10
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $14.67B
    Δ Market Cap
    $-30.77B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    BSX
    44.5% Overvalued
    Price is 44.5% above estimated fair value
    Current Price: $43.09
    Fair Value: $29.83
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    CRM
    55.3% Overvalued
    Price is 55.3% above estimated fair value
    Current Price: $244.75
    Fair Value: $157.57
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    BSX

    What growth rate is the market pricing in at $43?

    +10.1%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +8.9%

    The market implies +10.1% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +8.9%, reflecting heavy growth investment expected to generate future returns.

    CRM

    What growth rate is the market pricing in at $245?

    +9.1%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +1.9%

    The market implies +9.1% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +1.9%, reflecting heavy growth investment expected to generate future returns.

    Economic Moat Score

    Learn more →
    BSX
    66/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    CRM
    58/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    BSX
    -2.51
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    CRM
    -2.73
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    BSX
    Insiders 0.3%Institutions 94.8%Retail & Other 5.0%
    No. of Institutional Holders2,204
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    CRM
    Insiders 3.0%Institutions 87.5%Retail & Other 9.5%
    No. of Institutional Holders3,512
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    BSX
    5
    Buys (3M)
    8
    Buys (12M)
    Total value (12M): $10.04M
    MORANO SUSAN E.
    Director
    $100,408
    @ $49.22 · 2026-08-25
    HABIGER DAVID C
    Director
    $99,937
    @ $47.59 · 2026-08-05
    HABIGER DAVID C
    Director
    $56,887
    @ $48.13 · 2026-08-04
    MAHONEY MICHAEL F
    Chief Executive Officer
    $9.00M
    @ $48.33 · 2026-08-03
    LUDWIG EDWARD J.
    Director
    $227,400
    @ $45.48 · 2026-07-31
    LUDWIG EDWARD J.
    Director
    $202,914
    @ $56.68 · 2026-05-20
    HABIGER DAVID C
    Director
    $251,098
    @ $56.43 · 2026-05-20
    PEGUS CHERYL
    Director
    $99,987
    @ $56.49 · 2026-05-20
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    CRM
    0
    Buys (3M)
    4
    Buys (12M)
    Total value (12M): $26.52M
    ALBER LAURA
    Director
    $500,266
    @ $194.58 · 2026-03-19
    KIRK DAVID BLAIR
    Director
    $500,178
    @ $194.62 · 2026-03-18
    KIRK DAVID BLAIR
    Director
    $500,722
    @ $258.64 · 2025-12-17
    MORFIT G MASON
    Director and Beneficial Owner of more than 10% of a Class of Security
    $25.02M
    @ $260.58 · 2025-12-05
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    BSX
    0
    Sells (3M)
    6
    Sells (12M)
    Total value (12M): $29.27M
    MAHONEY MICHAEL F
    Chief Executive Officer
    $15.04M
    @ $93.49 · 2026-02-02
    BUTCHER ARTHUR C
    Officer
    $1.76M
    @ $101.55 · 2025-12-01
    ZANE ELLEN M
    Director
    $1.27M
    @ $98.28 · 2025-11-06
    FITZGERALD JOSEPH MICHAEL
    Officer
    $4.97M
    @ $99.47 · 2025-11-03
    ZANE ELLEN M
    Director
    $1.31M
    @ $101.38 · 2025-10-28
    FITZGERALD JOSEPH MICHAEL
    Officer
    $4.92M
    @ $98.47 · 2025-10-01
    FITZGERALD JOSEPH MICHAEL
    Officer
    $5.27M
    @ $105.43 · 2025-09-02
    BUTCHER ARTHUR C
    Officer
    $1.81M
    @ $104.63 · 2025-08-01
    FITZGERALD JOSEPH MICHAEL
    Officer
    $5.23M
    @ $104.63 · 2025-08-01
    FUJIMORI YOSHIAKI
    Director
    $310,378
    @ $106.99 · 2025-07-29
    LUDWIG EDWARD J.
    Director
    $424,120
    @ $106.03 · 2025-07-25
    FITZGERALD JOSEPH MICHAEL
    Officer
    $5.35M
    @ $106.97 · 2025-07-01
    FITZGERALD JOSEPH MICHAEL
    President
    $5.80M
    @ $102.88 · 2025-06-04
    MAHONEY MICHAEL F
    Chief Executive Officer
    $17.05M
    @ $103.69 · 2025-06-02
    LUDWIG EDWARD J.
    Director
    $418,368
    @ $104.59 · 2025-05-29
    BROWN VANCE R
    General Counsel
    $513,583
    @ $106.42 · 2025-05-21
    SORENSON JOHN BRADLEY
    Officer
    $477,957
    @ $104.54 · 2025-05-05
    BUTCHER ARTHUR C
    Officer
    $1.77M
    @ $102.06 · 2025-05-01
    MAHONEY MICHAEL F
    Chief Executive Officer
    $16.85M
    @ $102.48 · 2025-05-01
    BROWN VANCE R
    General Counsel
    $458,904
    @ $95.09 · 2025-04-21
    MAHONEY MICHAEL F
    Chief Executive Officer
    $16.45M
    @ $100.01 · 2025-04-01
    BROWN VANCE R
    General Counsel
    $486,702
    @ $100.85 · 2025-03-21
    WOODWORTH EMILY
    General Counsel
    $800,897
    @ $104.95 · 2025-03-04
    WOODWORTH EMILY
    Officer
    $999,872
    @ $101.13 · 2025-02-28
    MIRVISS JEFFREY B
    Officer
    $766,921
    @ $104.16 · 2025-02-25
    ZANE ELLEN M
    Director
    $1.42M
    @ $104.23 · 2025-02-24
    BROWN VANCE R
    General Counsel
    $504,993
    @ $104.64 · 2025-02-21
    SORENSON JOHN BRADLEY
    Officer
    $624,861
    @ $104.84 · 2025-02-19
    MIRVISS JEFFREY B
    Officer
    $159,078
    @ $105.35 · 2025-02-19
    BRENNAN DANIEL J
    Chief Financial Officer
    $8.92M
    @ $105.10 · 2025-02-19
    SORENSON JOHN BRADLEY
    Officer
    $127,678
    @ $106.31 · 2025-02-14
    MIRVISS JEFFREY B
    Officer
    $1.37M
    @ $105.06 · 2025-02-12
    SORENSON JOHN BRADLEY
    Officer
    $671,249
    @ $105.06 · 2025-02-12
    BRENNAN DANIEL J
    Chief Financial Officer
    $1.59M
    @ $105.07 · 2025-02-12
    LUDWIG EDWARD J.
    Director
    $1.27M
    @ $105.48 · 2025-02-11
    SORENSON JOHN BRADLEY
    Officer
    $685,244
    @ $104.97 · 2025-02-07
    BUTCHER ARTHUR C
    Officer
    $1.76M
    @ $101.80 · 2025-02-03
    MIRVISS JEFFREY B
    Officer
    $642,658
    @ $89.86 · 2025-01-03
    SORENSON JOHN BRADLEY
    Officer
    $581,241
    @ $89.96 · 2025-01-03
    BRENNAN DANIEL J
    Chief Financial Officer
    $870,636
    @ $89.86 · 2025-01-03
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    CRM
    1
    Sells (3M)
    14
    Sells (12M)
    Total value (12M): $40.38M
    CONWAY CRAIG
    Director
    $1.17M
    @ $260.61 · 2026-09-04
    KROES NEELIE
    Director
    $929,276
    @ $238.70 · 2026-01-14
    HARRIS G PARKER
    Officer and Director
    $31.61M
    @ $234.70 · 2025-12-02
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $575,140
    @ $255.62 · 2025-10-23
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $590,102
    @ $262.27 · 2025-10-21
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $567,631
    @ $252.28 · 2025-10-20
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $550,430
    @ $244.64 · 2025-10-17
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $558,810
    @ $248.36 · 2025-10-16
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $536,322
    @ $238.37 · 2025-10-15
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $548,796
    @ $243.91 · 2025-10-14
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $1.10M
    @ $244.75 · 2025-10-13
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $547,344
    @ $243.26 · 2025-10-09
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $539,533
    @ $239.79 · 2025-10-08
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $555,001
    @ $246.67 · 2025-09-23
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    BSX
    FearGreed
    😨Fear(30/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    CRM
    FearGreed
    😐Neutral(55/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    BSX
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (30)
    CRM
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (55)
    View BSX Full AnalysisView CRM Full Analysis

    Frequently Asked Questions: BSX vs CRM

    Is Boston Scientific Corporation or Salesforce, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, BSX trades at a -44.5% margin of safety (intrinsic value $30 vs. price $43), compared to CRM's -55.3% margin of safety (intrinsic $158 vs. $245).

    Which stock has a wider economic moat, Boston Scientific Corporation or Salesforce, Inc.?

    BSX scores 66/100 (Narrow moat), while CRM scores 58/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Which company has better free cash flow, Boston Scientific Corporation or Salesforce, Inc.?

    Salesforce, Inc. (CRM) generates a 8.8% free cash flow yield, compared to Boston Scientific Corporation's 5.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Boston Scientific Corporation or Salesforce, Inc.?

    BSX earns 10.0% ROIC versus CRM's 9.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.